skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Model of iodine metabolism in a T3-thyrotoxic patient undergoing I-131 therapy

Technical Report ·
DOI:https://doi.org/10.2172/7363203· OSTI ID:7363203

Data on radioactivity in the thyroid, urine, serum, butanol-extractable iodine (BEI) and chromatographic fractionations of BEI, obtained during four I-131 therapeutic treatments of a T3-thyrotoxic patient, have been analyzed and simulated with the help of a 7-compartment model. Good fits to most of the data can be obtained with both the dose-independent and dose-dependent models. A model with 3 or 4 compartments, which provides adequate fits to iodine kinetic data in most euthyroid and hyperthyroid patients is not satisfactory in the case of this patient. Thus, to represent iodine metabolism during T3-thyrotoxicosis therapy, we find that it is necessary to provide for separate biochemical pathways for the BEI components as well as the butanol-insoluble compounds released by the thyroid gland. (auth)

Research Organization:
Vanderbilt Univ., Nashville, Tenn. (United States). Div. of Nuclear Medicine and Biophysics; Cleveland Metropolitan General Hospital, Ohio (United States); National Cancer Inst., Bethesda, Md. (United States). Lab. of Theoretical Biology
Sponsoring Organization:
US Energy Research and Development Administration (ERDA)
OSTI ID:
7363203
Report Number(s):
ORO-2401-95; TRN: 76-015164
Country of Publication:
United States
Language:
English